Proportion of lung cancer patients eligible for screening in France: Data from the KBP-2020-CPHG study.

Couraud S, Grolleau E, Letreut J, Rizzo C, Saelens T, Marty C, Virally J, Lamotte F, Tack V, Bonnefoy P, Alizon C, Bugnet AS, Letierce A, Morel H, Debieuvre D

Open source

DOI: 10.1016/j.lungcan.2026.109498
Published: 2026 Aug
Container: Lung cancer (Amsterdam, Netherlands)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lungcan.2026.109498,
  title = {Proportion of lung cancer patients eligible for screening in France: Data from the KBP-2020-CPHG study.},
  author = {Couraud S and Grolleau E and Letreut J and Rizzo C and Saelens T and Marty C and Virally J and Lamotte F and Tack V and Bonnefoy P and Alizon C and Bugnet AS and Letierce A and Morel H and Debieuvre D},
  year = {2026},
  journal = {Lung cancer (Amsterdam, Netherlands)},
  doi = {10.1016/j.lungcan.2026.109498},
  url = {https://doi.org/10.1016/j.lungcan.2026.109498}
}

RIS

TY  - JOUR
TI  - Proportion of lung cancer patients eligible for screening in France: Data from the KBP-2020-CPHG study.
AU  - Couraud S
AU  - Grolleau E
AU  - Letreut J
AU  - Rizzo C
AU  - Saelens T
AU  - Marty C
AU  - Virally J
AU  - Lamotte F
AU  - Tack V
AU  - Bonnefoy P
AU  - Alizon C
AU  - Bugnet AS
AU  - Letierce A
AU  - Morel H
AU  - Debieuvre D
PY  - 2026
JO  - Lung cancer (Amsterdam, Netherlands)
DO  - 10.1016/j.lungcan.2026.109498
UR  - https://doi.org/10.1016/j.lungcan.2026.109498
ER  -

APA

S, C., E, G., J, L., C, R., T, S., C, M., J, V., F, L., V, T., P, B., C, A., AS, B., A, L., H, M., & D, D. (2026). Proportion of lung cancer patients eligible for screening in France: Data from the KBP-2020-CPHG study.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2026.109498

Source records

pubmed · retrieved 2026-09-26T20:48:26.382Z